Roman Czubatyj, MD
Rheumatology · Rochester Hills, MINPI 1972797892
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $673,350 of the $763,550 with a category attached, or 88.2%. Amgen accounts for 67.6% of it on its own, with 31 other manufacturers making up the rest. Among rheumatology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,815 payments — averaging $420.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$516K
- AbbVie$139K
- Johnson & Johnson$85K
- Janssen Scientific Affairs, LLC$18K
- UCB, Inc.$963
- Novartis$925
- plus $4K from 26 others
What the payments were for
- Consulting fees$13,3192%
- Speaking & faculty fees$673,35088%
- Grants$2400%
- Travel & lodging$43,6456%
- Food & beverage$32,4474%
- Education$5500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 909 | $515,830 |
| AbbVie | 310 | $138,709 |
| Johnson & Johnson | 295 | $85,321 |
| Janssen Scientific Affairs, LLC | 23 | $17,781 |
| UCB, Inc. | 25 | $963 |
| Novartis | 52 | $925 |
| Sanofi | 19 | $859 |
| Lilly USA, LLC | 35 | $565 |
| E.r. Squibb & Sons, L.L.C. | 46 | $533 |
| Pfizer | 39 | $478 |
| GSK | 15 | $465 |
| Sandoz | 8 | $176 |
| AstraZeneca(2 entities) | 7 | $150 |
| Intrafusion GP, LLC | 1 | $110 |
| Organon | 5 | $91 |
| Genentech USA, Inc. | 5 | $90 |
| Fresenius Kabi USA, LLC | 3 | $79 |
| Sanofi-aventis U.S. LLC | 1 | $65 |
| Pacira Therapeutics, Inc. | 2 | $50 |
| Cardinal Health Inc | 1 | $43 |
| Aurinia Pharma U.S., Inc. | 2 | $42 |
| Boehringer Ingelheim | 1 | $30 |
| Hikma Pharmaceuticals USA | 2 | $29 |
| Sobi, Inc | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$763,550 in reported general payments places this provider in the 95th percentile of 195 rheumatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 156 | $7,039 |
| Hydroxychloroquine Sulfate | 55 | $3,819 |
| Leflunomide | 62 | $3,281 |
| Sulfasalazine | 36 | $1,252 |
| Prednisone | 141 | $815 |
| Celecoxib | 22 | $631 |
| Allopurinol | 40 | $480 |
| Colchicine | 13 | $466 |
| Sulfasalazine DrSulfasalazine | 11 | $460 |
| Gabapentin | 15 | $242 |
| Folic Acid | 20 | $146 |
| Meloxicam | 23 | $111 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Rochester Hills
- Patricia CagnoliRochester Hills$89K
- John TowerRochester Hills$35K
- Dana RockwellRochester Hills$16K
- Josephine AlootRochester Hills$15K
- Phyllis BirkelRochester Hills$14K
- Amar MajjhooSaint Clair Shores$1.8M
- Andrew SulichSaint Clair Shores$1.7M
- Dinesh KhannaAnn Arbor$1.2M
- Delfin SantosRochester$242K
- Allan MortonWarren$229K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.